Cargando...
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer
OBJECTIVES: Effective management of adverse events (AEs) following vandetanib treatment is important to maximize clinical benefits. We examined whether more frequent contact with vandetanib-treated patients reduced AEs of CTCAE grade 2 or higher. STUDY DESIGN: In this open-label, multicentre, phase...
Guardado en:
| Publicado en: | Eur Thyroid J |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger AG
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5091223/ https://ncbi.nlm.nih.gov/pubmed/27843809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448919 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|